Loading clinical trials...
Loading clinical trials...
During a first consultation with an indication of total hysterectomy for a benign lesion, we will study the patient's eligibility. After explanations of the study and submission of the forms, the pati...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Clermont-Ferrand
NCT07362680 · Total Laparoscopic Hysterectomy, Atelectasis, Postoperative
NCT07326683 · Total Laparoscopic Hysterectomy
NCT07289295 · Robotic Assisted Hysterectomy and/or Salpingo-oophorectomy
NCT07232108 · Postoperative Pain Management, Laparoscopic Hysterectomy, and more
NCT07233811 · Hysterectomy, Same Day Discharge, and more
CHU clermont-ferrand
Clermont-Ferrand
CH d'Issoire
Issoire
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions